Neurological manifestations of organic acid disorders

Neurological manifestations are very common and can be the leading and/or presenting feature in organic acid disorders, sometimes in the absence of metabolic derangement. Review of the time course and presentation of neurological disease in organic acid disorders reveals characteristic clinical find...

Full description

Saved in:
Bibliographic Details
Main Authors: Hoffmann, Georg F. (Author) , Gibson, K. M. (Author) , Trefz, Friedrich K. (Author) , Nyhan, W. L. (Author) , Bremer, Hans J. (Author) , Rating, Dietz (Author)
Format: Article (Journal)
Language:English
Published: 1994
In: European journal of pediatrics
Year: 1994, Volume: 153, Pages: S94-S100
ISSN:1432-1076
DOI:10.1007/BF02138786
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/BF02138786
Get full text
Author Notes:G.F. Hoffmann, K.M. Gibson, F.K. Trefz, W.L. Nyhan, H.J. Bremer, D. Rating
Description
Summary:Neurological manifestations are very common and can be the leading and/or presenting feature in organic acid disorders, sometimes in the absence of metabolic derangement. Review of the time course and presentation of neurological disease in organic acid disorders reveals characteristic clinical findings of ataxia, myoclonus, extrapyramidal symptoms, metabolic stroke and megalencephaly. A group of organic acid disorders presents exclusively with neurological symptoms. These include glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I), succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria), mevalonic aciduria,n-acetylaspartic aciduria (Canavan disease) andl-2-hydroxyglutaric aciduria. As a group these “cerebral” orgamic acid disorders appear to remain often undiagnosed and their true incidence is much less wellknown than that of the “classical” organic acid disorders. Unfortunately, stringent guidelines for a clinical preselection of neuropaediatric patients to be investigated for organic acid disorders cannot be provided. Today, screening for neurometabolic disorders should be as comprehensive as possible and include determinations of amino acids, purines and pyrimidines and markers of peroxisomal function in addition to organic acid analysis.
Item Description:Gesehen am 17.06.2024
Physical Description:Online Resource
ISSN:1432-1076
DOI:10.1007/BF02138786